Q4 Results Outcome 1st June Highlights: IndiGo & NMDC Steel soar post Q4, IREDA, Inox Wind, Natco Pharma & Glenmark shares fall
2026-06-01 15:44:05Q4 Results Outcome 1st June Highlights: IndiGo & NMDC Steel soar post Q4, IREDA, Inox Wind, Natco Pharma & Glenmark shares fall BusinessLine...
Read MoreNatco Pharma stock price slips 20% in 2 days; should you buy, sell or hold?
2026-06-01 11:45:20Natco Pharma stock price slips 20% in 2 days; should you buy, sell or hold? Business Standard...
Read MoreQ4 Results 29th May Live: IndiGo posts Q4 loss, RCOM loss widens, Natco Pharma & BEML Q4 profit down, Asian Paints & IPCA Lab profit up y-o-y, Glenmark Pharma, IREDA, Gujarat Gas, NMDC, JM Financial to announce Q4 results
2026-05-29 18:30:59Q4 Results 29th May Live: IndiGo posts Q4 loss, RCOM loss widens, Natco Pharma & BEML Q4 profit down, Asian Paints & IPCA Lab profit up y-o-y, Glenmark Pharma, IREDA, Gujarat Gas, NMDC, JM Financial to announce Q4 results BusinessLine...
Read MoreNatco Pharmas Q4 net down 34% at 269 cr
2026-05-29 16:51:32Natco Pharmas Q4 net down 34% at 269 cr BusinessLine...
Read MoreAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
04-Jun-2026 | Source : BSEEarning call Transcript for the concall held on May 29 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
03-Jun-2026 | Source : BSENATCO Pharma Limited and Lupin Limited receive approval from U.S. FDA for Eribulin Mesylate Injection
Announcement under Regulation 30 (LODR)-Newspaper Publication
30-May-2026 | Source : BSENewspaper Publication of Annual Audited Financial Results for the Quarter and Year ended March 31 2026
Corporate Actions
No Upcoming Board Meetings
Natco Pharma Ltd. has declared 75% dividend, ex-date: 18 Feb 26
Natco Pharma Ltd. has announced 2:10 stock split, ex-date: 26 Nov 15
No Bonus history available
No Rights history available